Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia?

Clin Microbiol Infect. 2016 Jun;22(6):576. doi: 10.1016/j.cmi.2016.02.008. Epub 2016 Feb 27.

Authors

M Abe¹, M Kimura², H Araoka³, S Taniguchi⁴, A Yoneyama³

Affiliations

¹ Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan. Electronic address: hamutaro1292@gmail.com.
² Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
³ Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
⁴ Department of Haematology, Toranomon Hospital, Tokyo, Japan.

PMID: 26928201
DOI: 10.1016/j.cmi.2016.02.008

No abstract available

Publication types

Letter

MeSH terms

Candidemia / diagnosis*
Candidemia / mortality*
Candidemia / pathology
Humans
Prognosis
Proteoglycans
Serum / chemistry*
Survival Analysis
beta-Glucans / blood*

Substances

Proteoglycans
beta-Glucans
polysaccharide-K